Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Covelli

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Archives of Gynecology and Obstetrics|January 1, 1993
Effects of an oral contraceptive combination containing 0.150 mg desogestrel plus 0.020 mg ethinyl estradiol on healthy premenopausal womenD de Aloysio, M Mauloni, A Roncuzzi, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1987
Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoidesR Simoni, R Cavalieri, G Coppola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204S Amadori, A Ceci, A Comelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1980
Globin chain synthesis in single erythroid bursts from cord blood: studies on gamma leads to beta and G gamma leads to A gamma switchesP Comi, B Giglioni, S Ottolenghi, et al.
European Journal of Haematology|January 1, 1989
High-dose Ara-C (HiDAC) plus asparaginase in elderly patients with acute non-lymphocytic leukemia: a pilot multicentric study by the Italian Cooperative Group GIMEMAM C Petti, F Mandelli, G Avvisati, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 31, 1994
Desogestrel versus gestodene in oral contraceptives: influence on the clinical and histomorphological features of benign breast diseaseA Di Lieto, G De Rosa, G Albano, et al.
Blood|August 1, 1980
Hemoglobin synthesis in individual bursts from normal adult blood: all bursts and subcolonies synthesize G gamma-and A gamma-globin chainsC Peschle, G Migliaccio, A Covelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemiaU Tidefelt, J Liliemark, A Gruber, et al.
Leukemia|May 23, 2001
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemiaG Visani, D Milligan, F Leoni, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC)R Advani, G Visani, D Milligan, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Archives of Gynecology and Obstetrics|January 1, 1993
Effects of an oral contraceptive combination containing 0.150 mg desogestrel plus 0.020 mg ethinyl estradiol on healthy premenopausal womenD de Aloysio, M Mauloni, A Roncuzzi, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1987
Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoidesR Simoni, R Cavalieri, G Coppola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204S Amadori, A Ceci, A Comelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1980
Globin chain synthesis in single erythroid bursts from cord blood: studies on gamma leads to beta and G gamma leads to A gamma switchesP Comi, B Giglioni, S Ottolenghi, et al.
European Journal of Haematology|January 1, 1989
High-dose Ara-C (HiDAC) plus asparaginase in elderly patients with acute non-lymphocytic leukemia: a pilot multicentric study by the Italian Cooperative Group GIMEMAM C Petti, F Mandelli, G Avvisati, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 31, 1994
Desogestrel versus gestodene in oral contraceptives: influence on the clinical and histomorphological features of benign breast diseaseA Di Lieto, G De Rosa, G Albano, et al.
Blood|August 1, 1980
Hemoglobin synthesis in individual bursts from normal adult blood: all bursts and subcolonies synthesize G gamma-and A gamma-globin chainsC Peschle, G Migliaccio, A Covelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemiaU Tidefelt, J Liliemark, A Gruber, et al.
Leukemia|May 23, 2001
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemiaG Visani, D Milligan, F Leoni, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC)R Advani, G Visani, D Milligan, et al.
Pageof 3